Skip to content
Health · World
New FDA approvals for ESR1 mutation offer hope in metastatic breast cancer
1 sourceFirst reported 1 hour agoUpdated 1 hour ago
AI summary: catch up in 20 seconds
Summarising the coverage…
Generated by AI from the 1 sources below · always verify with the originals
All coverage (1)
In this storyPharmaceuticals
Comments · 0 (subscribers)
Sign in to join the discussion.
No comments yet. Be the first to join the discussion.